M&A Deal Summary

Becton Dickinson Acquires Accuri Cytometers

On February 7, 2011, Becton Dickinson acquired life science company Accuri Cytometers

Acquisition Highlights
  • This is Becton Dickinson’s 4th transaction in the Life Science sector.
  • This is Becton Dickinson’s 8th transaction in the United States.
  • This is Becton Dickinson’s 2nd transaction in Michigan.

M&A Deal Summary
Date 2011-02-07
Target Accuri Cytometers
Sector Life Science
Buyer(s) Becton Dickinson
Deal Type Add-on Acquisition

Target

Accuri Cytometers

Ann Arbor, Michigan, United States
Accuri Cytometers, Inc. was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Becton Dickinson

Franklin Lake, New Jersey, United States
Category Company
Founded 1897
Sector Medical Products
Employees75,000
Revenue 19.4B USD (2023)
DESCRIPTION

Becton Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. Becton Dickinson was incorporated in 1897 and is headquartered in Franklin Lake, New Jersey.

DEAL STATS #
Overall 8 of 30
Sector (Life Science) 4 of 7
Type (Add-on Acquisition) 8 of 25
State (Michigan) 2 of 2
Country (United States) 8 of 23
Year (2011) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-04 Becton Dickinson - Critical Care & Extended Dwell Catheter Product

Franklin Lake, New Jersey, United States

Becton, Dickinson and Co. - Critical Care & Extended Dwell Catheter Product consisting of blood pressure monitoring devices, and central venous, pulmonary artery and extended dwell catheters.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-27 Carmel Pharma AB

Molndal, Sweden

Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment.

Buy -
Mergr

Product

Company

Legal